Apr. 03, 2018News & Opinions
On Apr. 2, 2018, Erez Israeli joined Indian pharmaceutical company Dr. Reddy’s as COO and global head of Generics & PSAI. Israeli, former president & CEO of Enzymotec, succeeded Abhijit Mukherjee, who retired on Mar. 31, ...
Mar. 19, 2018Topics
Trade shows are excellent places to learn more about the state of an industry. Last month Pharmapack Europe offered a firsthand look at some of the changes and new trends that are shaping the drug industry — including new ...
Mar. 09, 2018News & Opinions
Martin Shkreli, who gained notoriety in 2015 for jacking up the price of Daraprim (pyrimethamine), a 62-year-old drug used to treat toxoplasmosis, has been ordered by a US federal judge to pay almost $7.4 million for defrauding investors ...
Mar. 08, 2018News & Opinions
Catalent Pharma Solutions has completed the $4.6 million expansion at its Singapore clinical supply facility, announced in Feb. 2016. The New Jersey, USA-based company said the expansion provides additional GMP space for secondary ...
Mar. 06, 2018News & Opinions
The EU and the US Food and Drug Administration (FDA) have extended their agreement on recognizing each other’s medicines inspections to include Greece, Hungary, Czech Republic and Romania with effect from Mar. 1. ...
Feb. 28, 2018Topics
ChemSpec Europe 2018: The Fine and Specialty Chemicals exhibition, taking place 20 – 21 June 2018 at Koelnmesse in Cologne, Germany, is known for being a key marketplace for sourcing and trading of fine and specialty chemicals for a ...
Feb. 27, 2018Topics
Contract development and manufacturing organization (CDMO) Lonza said it exceeded its full-year 2017 guidance. The company reported sales of CHF 5.1 billion. Having closed the acquisition of Capsugel in July 2017, Lonza consolidated the ...
Jan. 17, 2018Topics
Japan has the world’s third largest pharma industry. Yet, for many international companies the market has not proved easy to access. Very high barriers to entry have combined with a historically insular domestic market to limit ...
Dec. 18, 2017Topics
As Austria’s second largest sector, the chemical industry is also among its most important. Spending on chemical research and innovation also surpasses that of other sectors. At present, it represents around 11% of all investments ...
Dec. 13, 2017News & Opinions
From Jan. 1, 2018, Bayer will streamline its strategic pharmaceutical research and development activities and combine them under a single unit covering the therapeutic areas cardiology, gynecology, ophthalmology, hematology and oncology.
The latest information directly via newsletter.